EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort

Veronica Marcoux iD, Stacey D Lok, Prosanta Mondal, Deborah Assayag, Jolene H Fisher iD, Shane Shapera, Julie Morisset, Hélène Manganas, Charlene D Fell, Nathan Hambly, P Gerard Cox, Martin Kolb iD und 9 weitere

Respirology · 2024-07 · 29 (7) · 596-604

DOI: 10.1111/resp.14695 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Respirology, online erschienen am 04.03.2024. Verfasst von Veronica Marcoux und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Registries, Lung. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Establishing an accurate and timely diagnosis of idiopathic pulmonary fibrosis (IPF) is essential for appropriate management and prognostication. In some cases, surgical lung biopsy (SLB) is performed but carries non‐negligible risk. The objective of this retrospective study was to determine if SLB is associated with accelerated lung function decline in patients with IPF using the Canadian Registry for Pulmonary Fibrosis.

Methods

Linear mixed models and Cox proportional hazards regression models were used to compare decline in forced vital capacity (FVC)%, diffusion capacity of the lung (DLCO%) and risk of death or lung transplantation between SLB and non‐SLB patients. Adjustments were made for baseline age, sex, smoking history, antifibrotic use, and lung function. A similar analysis compared lung function changes 12 months pre‐ and post‐SLB.

Results

A total of 81 SLB patients and 468 non‐SLB patients were included. In the SLB group, the post‐biopsy annual FVC% decline was 2.0% (±0.8) in unadjusted, and 2.1% (±0.8) in adjusted models. There was no difference in FVC% decline, DLCO% decline, or time to death or lung transplantation between the two groups, in adjusted or unadjusted models (all p ‐values >0.07). In the pre‐post SLB group, no differences were identified in FVC% decline in unadjusted or adjusted models ( p = 0.07 for both).

Conclusion

No association between SLB and lung function decline or risk of death or lung transplantation was identified in this multi‐centre study of patients with IPF. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisRegistriesLungHumansMaleFemaleRetrospective StudiesMiddle AgedBiopsyAgedVital CapacityLung TransplantationCanadaRespiratory Function TestsPrognosisProportional Hazards ModelsCohort StudiesSurvival Rate

Stichwörter der Autor:innen

idiopathic pulmonary fibrosisinterstitial lung diseaselung functionlung transplantationoutcomesrisk of deathsurgical lung biopsy

Autor:innen und Institutionen

  • Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Department of Community Health & Epidemiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Department of Medicine, McGill University, Montreal, Quebec, Canada.
  • Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medicine, Université de Montreal, Montreal, Quebec, Canada.
  • Department of Medicine, University of Calgary, Calgary, Alberta, Canada.

ORCID-Profile: Veronica Marcoux, Jolene H Fisher, Martin Kolb, Andrea S Gershon, Alyson W Wong, Christopher J Ryerson, Kerri A Johannson

Förderung

  • Boehringer Ingelheim

Zitieren

APA

Marcoux, V., Lok, S. D., Mondal, P., Assayag, D., Fisher, J. H., Shapera, S., Morisset, J., Manganas, H., Fell, C. D., Hambly, N., Cox, P. G., Kolb, M., Gershon, A. S., To, T., Sadatsafavi, M., Khalil, N., Wong, A. W., Wilcox, P. G., Ryerson, C. J., …, & Johannson, K. A. (2024). Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort. Respirology, 29(7), 596-604. https://doi.org/10.1111/resp.14695

Vancouver

Marcoux V, Lok SD, Mondal P, Assayag D, Fisher JH, Shapera S, et al. Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort. Respirology. 2024;29(7):596-604. doi:10.1111/resp.14695

BibTeX
@article{Marcoux2024,
  author = {Marcoux, Veronica and Lok, Stacey D and Mondal, Prosanta and Assayag, Deborah and Fisher, Jolene H and Shapera, Shane and Morisset, Julie and Manganas, Hélène and Fell, Charlene D and Hambly, Nathan and Cox, P Gerard and Kolb, Martin and Gershon, Andrea S and To, Teresa and Sadatsafavi, Mohsen and Khalil, Nasreen and Wong, Alyson W and Wilcox, Pearce G and Ryerson, Christopher J and Vu, Thao and Johannson, Kerri A},
  title = {Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort},
  journal = {Respirology},
  year = {2024},
  volume = {29},
  number = {7},
  pages = {596--604},
  doi = {10.1111/resp.14695}
}
Kostenlos starten →